P3.02c-051 A Pre-Treatment Serum Test Based on Complement and IL-10 Pathways Identifies Patients Benefiting from the Addition of Bavituximab to Docetaxel: Topic: IT
- Resource Type
- Abstract
- Source
- In
Journal of Thoracic Oncology January 2017 12(1) Supplement:S1305-S1306 - Subject
- Language
- ISSN
- 1556-0864